Publications by authors named "Sachchidanand S"

Bacterial DNA gyrase and topoisomerase IV inhibition has emerged as a promising strategy for the cure of infections caused by antibiotic-resistant bacteria. The Novel Bacterial Topoisomerase Inhibitors (NBTIs) bind to a different site from that of the quinolones with novel mechanism of action. This evades the existing target-mediated bacterial resistance associated with quinolones.

View Article and Find Full Text PDF
Article Synopsis
  • Dysregulated JAK-STAT signaling is linked to immune-mediated diseases, leading to the approval of JAK inhibitors for conditions like rheumatoid arthritis and inflammatory bowel disease.
  • Researchers designed and optimized momelotinib analogues to develop pan-JAK inhibitors, focusing on the compound 32 which effectively inhibits JAK1, JAK2, and JAK3.
  • Preclinical evaluations showed that compound 32 has better pharmacokinetic properties and greater anti-inflammatory effects compared to the original momelotinib, advancing it into further development.
View Article and Find Full Text PDF

Selective inhibition of janus kinase (JAK) has been identified as an important strategy for the treatment of autoimmune disorders. Optimization at the C2 and C4-positions of pyrimidine ring of Cerdulatinib led to the discovery of a potent and orally bioavailable 2,4-diaminopyrimidine-5-carboxamide based JAK3 selective inhibitor (11i). A cellular selectivity study further confirmed that 11i preferentially inhibits JAK3 over JAK1, in JAK/STAT signaling pathway.

View Article and Find Full Text PDF

The discovery of a series of thiophenephenylsulfonamides as positive allosteric modulators (PAM) of α7 nicotinic acetylcholine receptor (α7 nAChR) is described. Optimization of this series led to identification of compound a novel PAM of α7 nicotinic acetylcholine receptor (α7 nAChR). Compound showed good in vitro potency, with pharmacokinetic profile across species with excellent brain penetration and residence time.

View Article and Find Full Text PDF

PI3Kδ is implicated in various inflammatory and autoimmune diseases. For the effective treatment of chronic immunological disorders such as rheumatoid arthritis, it is essential to develop isoform selective PI3Kδ inhibitors. Structure guided optimization of an imidazo-quinolinones based pan-PI3K/m-TOR inhibitor (Dactolisib) led to the discovery of a potent and orally bioavailable PI3Kδ isoform selective inhibitor (10h), with an improved efficacy in the animal models.

View Article and Find Full Text PDF

Acid-sensing ion channels (ASICs) are associated with many pathophysiological processes, such as neuronal death during ischemic stroke, epileptic seizure and nociception. However, there is a dearth of ASIC-specific therapeutic blockers. Here we report that quercetin, a plant flavonoid, which is known for its neuroprotective effect, reversibly inhibits homomeric rat ASIC1a, ASIC2a and ASIC3 with an IC of about 2µM.

View Article and Find Full Text PDF

Our previous studies have shown that overexpression of MDR1 and cyclooygenase-2 (COX-2) resulted in resistance development to imatinib in chronic myelogenous leukemia (CML) K562 (IR-K562) cells. In the present study, the regulatory mechanism of MDR1 induction by COX-2 was investigated. A gradual overexpression of MDR1 and COX-2 during the process of development was observed.

View Article and Find Full Text PDF